Replies to post #2245 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Current Insider Shareholdings

[As of Jan 5, 2007. Options include those
that are exercisable now or within 60 days.]

 
  
 Executive Officers  
 Geoffrey Cox, CEO          218K shares   645K options 
 John Green, CFO            109K shares   282K options 
 Harry Meade, SVP Research  107K shares   231K options 
 Dan Woloshen, Gen. Counsel  81K shares   170K options 
 Greg Liposky, SVP Oprtns    51K shares   215K options 
 Dick Scotland, SVP Regltry  60K shares   120K options 
 -- 
 Six executive officers     626K shares 1,672K options

 
 Independent directors  
 Robert Baldridge             5K shares    60K options 
 Kenneth Bauer                 0 shares    23K options 
 Christian Béchon              0 shares    23k options 
 Francis Bullock              5K shares    66K options 
 James Geraghty              68K shares   148K options 
 Michael Landine               0 shares    15K options 
 Pamela McNamara              5K shares    37K options 
 Marvin Miller                4K shares    38K options 
 Alan Tuck                   10K shares    43K options 
 -- 
 Nine independent directors  97K shares   453K options

 
 All officers/directors     723K shares 2,125K options